Capital Flow Monitor · Sponsors · CIK 2083708
Anserine Labs, Inc.
26 WESTWOOD HOUSE, LONDON, X0, SW12 9RF · 44 7584 887239
Other Technology · Corporation· inc. DELAWARE true 2025
Fit score
—
Offering
$3.5M
Sold
$3.4M
% sold
98.3%
Investors
21
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-08-28 | D ·current | 506(b) | $3.5M | $3.4M | 98.3% | 21 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Jackson Gabbard — Executive Officer / Director / Promoter, London, X0
-
David Miller — Executive Officer / Director / Promoter, London, X0
6 other raises
- North Haven Venture Capital Opportunities Fund II (Cayman) LP $0 of —
- North Haven Venture Capital Opportunities Fund II LP $0 of —
- TOCA Football, Inc. $3.1M of $3.1M · 100.0%
- Boston Materials, Inc. $28.3M of $28.3M · 100.0%
- North Haven Tactical Value II Co-Invest LP $0 of —
- VOLEXION, INC. $1.4M of $2.0M · 71.8%
- Joshua Watzman — Director / Promoter, London, X0
- Julien Codorniou — Director, London, X0
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.